Spectrum of Mucocutaneous Reactions to COVID-19 Vaccination: A Report from India

    March 2022 in “ PubMed ”
    Abheek Sil, Deepak Jakhar, Anupam Das … Sujala Sacchidanand Aradhya
    Studysummary In this study, 19.6% of COVID-19 vaccine recipients reported post-vaccination mucocutaneous effects, mostly mild and self-limiting; the reactions were similarly frequent for Covishield and Covaxin.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on pubmed.ncbi.nlm.nih.gov →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Exacerbation of Subacute Cutaneous Lupus Erythematosus Following Vaccination with BNT162b2 mRNA Vaccine Dermatologic Therapy · 2021